期刊文献+

多西他赛联合奥沙利铂、氟尿嘧啶治疗晚期胃癌的临床分析 被引量:2

Clinical efficacy of the advanced gastric cancer treated with the regimen of docetaxel, oxaliplatin and fluorouracil
下载PDF
导出
摘要 目的 评价多西他赛(DOCE)、奥沙利铂(L-OHP)、氟尿嘧啶(FU)联合方案对晚期胃癌的治疗效果和毒副反应.方法 32例晚期胃癌患者均行锁骨下深静脉穿刺或外周肘正中静脉置管,FU由静脉输液泵泵入.化疗方案:DOCE 75 mg/m2,静脉滴注1h,第1天;L-OHP 130 mg/m2,静脉滴注2h,第1天;FU 750 mg/m2,持续静脉泵入120 h,第1~5天.28 d为1个周期,至少应用2个周期进行疗效评估.结果 32例患者中,完全缓解1例,部分缓解14例,稳定8例,进展9例,总有效率为46.9%,疾病总控制率为69.7%.肿瘤中位进展时间6.2个月,中位生存时间11.1个月,1年生存率为40.6%.主要毒性反应包括白细胞减少、胃肠道反应、神经毒性和脱发.结论 DOF方案疗效显著、毒副反应可耐受,可以作为晚期胃癌的有效化疗方案. Objective To assess the efficacy and toxicity of DOF regimen consisting of docetaxel,oxaliplatin and fluorouracil for advanced gastric cancer. Methods 32 cases of patients with advanced gastric cancer were deep lines of subclavian vein puncture or peripheral elbow in the middle of venipuncture,FU by intravenous infusion pump pumping. Chemotherapy regimens:docetaxel and oxaliplatin were given intravenously at a dose of 75 mg/m2 and 130 mg/m2 for 1 h and 2 h on dl,respectively,and FU was administered as continuous intravenous infusion for 120 h at a dose of 750 mg/m2 on dl-d5.This regimen was repeated every 28 d.The efficacy and toxicity were evaluated after completion of 2 cycles at least. Results Of the 32 patients,1 case achieved complete response,14 cases achieved a partial response,8 cases had stable disease,and 9 cases showed progressive disease.The overall response rate of this series was 46.9%,and overall disease control rate was 69.7%.The median time to progression was 6.2 months,and median overall survival was 11.1 months.The 1 year survival rate was 40.6%.The major toxicities were leukoeytopenia,nausea/vomiting, peripheral neuritis and alopecia. Conclusion The DOF regimen of docetaxel,oxaliplatin and fluorouracil is effective and tolerable for advanced gastric cancer,and can be an good choice for advanced gastric cancer.
出处 《中国当代医药》 2013年第35期60-61,63,共3页 China Modern Medicine
关键词 胃肿瘤 多西他赛 奥沙利铂 氟尿嘧啶 化疗 Gastric neoplasms Docetaxel Oxalipatin Fluorouracil Chemotherapy
  • 相关文献

参考文献12

  • 1Ajani JA. Recent developments in cytotoxic therapy for advanced gastric or gastroesophageal carcinoma:the phase Ⅲ trials[J].Gastrointest Cancer Res,2007,(2 Suppl):S16-S21. 被引量:1
  • 2Therasse P,Arbuck SG,Eisenhauer EA. New guidelines to evaluate the response to treatment in solid tumors European Organization for Research and Treatment of Cancer,National Cancer Institute of the United States,National Cancer Institute of Canada[J].{H}JOURNAL OF THE NATIONAL CANCER INSTITUTE,2000,(03):205-216. 被引量:1
  • 3Koizumi W,Narahara H,Hara T. S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial):a phase Ⅲ trial[J].{H}LANCET ONCOLOGY,2008,(03):215-221. 被引量:1
  • 4Van Cutsem E,Moiseyenko V M,Tjulandin S. Phase Ⅲ study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line therapy for advanced gastric cancer:a report of the V325 Study Group[J].{H}Journal of Clinical Oncology,2006,(31):4991-4997. 被引量:1
  • 5王哲海,郭珺,陈阵,李长征,盛立军,周登光,刘波,刘杰,王庆才,张恩宁.多西紫杉醇联合奥沙利铂和5-氟尿嘧啶双周方案治疗晚期胃癌的初步研究[J].中华肿瘤杂志,2008,30(5):389-391. 被引量:6
  • 6Al-Batran SE,Hartmann JT,Hofheinz R. Biweekly fluorouracil,leucovorin,oxaliplatin,and docetaxel (FLOT) for patients with metastatic adenocarcinoma of the stomach or esophagogastric junction:a phase Ⅱ trial of the Arbeitsgemeinschaft Intemistische Onkologie[J].Arm Oncol,2008,(11):1882-1887. 被引量:1
  • 7Sym SJ,Ryu MH,Kang HJ. Phase Ⅰ study of 3-weekly doeetaxel,capecitabine and oxaliplatin combination chemotherapy in patients with previously untreated advanced gastric cancer[J].{H}Cancer Chemotherapy and Pharmacology,2010,(02):373-380. 被引量:1
  • 8Amarantidis K,Xenidis N,Chelis L. Docetaxel plus oxaliplatin in combination with capecitabine as first-line treatment for advanced gastric cancer[J].{H}ONCOLOGY-BASEL,2011,(5-6):359-365. 被引量:1
  • 9Zaniboni A,Meriggi F. The emerging role of oxaliplatin in the treatment of gastric cancer[J].J Chemother,2005,(06):656-662. 被引量:1
  • 10郝代钧,樊建淑,张玲.多西紫杉醇联合奥沙利铂5-氟脲嘧啶和亚叶酸钙治疗晚期胃癌的临床研究[J].中国肿瘤临床,2007,34(16):953-955. 被引量:11

二级参考文献11

共引文献19

同被引文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部